1. Home
  2. ZLAB vs SEMR Comparison

ZLAB vs SEMR Comparison

Compare ZLAB & SEMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZLAB
  • SEMR
  • Stock Information
  • Founded
  • ZLAB 2013
  • SEMR 2008
  • Country
  • ZLAB China
  • SEMR United States
  • Employees
  • ZLAB N/A
  • SEMR N/A
  • Industry
  • ZLAB Biotechnology: Pharmaceutical Preparations
  • SEMR EDP Services
  • Sector
  • ZLAB Health Care
  • SEMR Technology
  • Exchange
  • ZLAB Nasdaq
  • SEMR Nasdaq
  • Market Cap
  • ZLAB 3.4B
  • SEMR 1.1B
  • IPO Year
  • ZLAB 2017
  • SEMR 2021
  • Fundamental
  • Price
  • ZLAB $31.91
  • SEMR $7.49
  • Analyst Decision
  • ZLAB Buy
  • SEMR Buy
  • Analyst Count
  • ZLAB 6
  • SEMR 8
  • Target Price
  • ZLAB $57.22
  • SEMR $14.88
  • AVG Volume (30 Days)
  • ZLAB 815.7K
  • SEMR 1.2M
  • Earning Date
  • ZLAB 11-11-2025
  • SEMR 11-06-2025
  • Dividend Yield
  • ZLAB N/A
  • SEMR N/A
  • EPS Growth
  • ZLAB N/A
  • SEMR N/A
  • EPS
  • ZLAB N/A
  • SEMR N/A
  • Revenue
  • ZLAB $427,799,000.00
  • SEMR $413,962,000.00
  • Revenue This Year
  • ZLAB $42.62
  • SEMR $20.28
  • Revenue Next Year
  • ZLAB $55.12
  • SEMR $16.41
  • P/E Ratio
  • ZLAB N/A
  • SEMR N/A
  • Revenue Growth
  • ZLAB 32.56
  • SEMR 22.16
  • 52 Week Low
  • ZLAB $20.17
  • SEMR $7.01
  • 52 Week High
  • ZLAB $44.34
  • SEMR $18.74
  • Technical
  • Relative Strength Index (RSI)
  • ZLAB 46.17
  • SEMR 42.77
  • Support Level
  • ZLAB $26.67
  • SEMR $7.32
  • Resistance Level
  • ZLAB $33.06
  • SEMR $7.90
  • Average True Range (ATR)
  • ZLAB 1.37
  • SEMR 0.22
  • MACD
  • ZLAB 0.08
  • SEMR 0.02
  • Stochastic Oscillator
  • ZLAB 65.76
  • SEMR 24.50

About ZLAB Zai Lab Limited

Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-1218 (CCR8) Solid Tumors, ZL-1310 (DLL3 ADC) ES-SCLC Other NECs, ZL-6301 (ROR1 ADC) Solid Tumors, ZL 6201 (LRRC15 ADC) Solid Tumors.

About SEMR SEMrush Holdings Inc.

SEMrush Holdings Inc is engaged in the online visibility management software-as-a-service (SaaS) platform. Its platform utilizes data and intelligence at the core surrounded by AI-powered interconnected hubs focused on search engine optimization, paid advertising, social media management, local marketing, brand marketing, and content marketing Geographically, it generates revenues from the United States, the UK, and Others.

Share on Social Networks: